Bacterial Dysbiosis
Dysbiosis is usually defined as an “imbalance” within the gut
microbial community that's related to disease. This imbalance could be due to the gain or loss of community members or changes in relative abundance of microbes. This theory primarily focuses on changes in the taxonomic make-up of the
microbial community and functions associated with individual members or subsets of members in the community. Characterizing dysbiosis has traditionally relied on taxonomic catalogs of gut microbes generated in different individuals at single time points using 16S or 18S rRNA sequencing. More recent efforts have attempted to catalog not the
microbial species, but rather the
microbial genes in the gut using shotgun metagenomics. The taxonomic characterization or genetic make-up of the community is then wont to infer its functions supported data within the literature from studies using reference
microbial strains. Usually, these
model microbes are studied as single organisms, and sometimes in vitro so as to get these functional data.Dysbiosis could cause or contribute to IBD during a number of different ways. It could lead to gain of one or more microbes with functions detrimental to the host or loss of one or more microbes with functions beneficial to the host. Since many of the microbes in the gut community have important functional relationships with each other, changes in a small number of microbes and/or their functions could have broad impacts on the community.
High Impact List of Articles
-
Antibiotic treatment in exacerbations of chronic obstructive pulmonary disease: recent trial results
Kavina Manalan, Taslima Rashid & Aran Singanayagam
Clinical Trail Outcomes: Clinical Investigation
-
Antibiotic treatment in exacerbations of chronic obstructive pulmonary disease: recent trial results
Kavina Manalan, Taslima Rashid & Aran Singanayagam
Clinical Trail Outcomes: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Non-inferiority designs and novel antimicrobials
Giorgio Tarchini
Editorial: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
Community-based study highlights the importance of recruiting homeless persons in smoking cessation trials
News and Views: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery & Amy B Heimberger
Proceedings: Clinical Investigation
-
miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma
Krishan Jethwa, Jun Wei, Kayla McEnery & Amy B Heimberger
Proceedings: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
-
Data and safety monitoring boards of randomized trials: evolving principles and practical suggestions
Charles H Hennekens,David DeMets4
Review Article: Clinical Investigation
Relevant Topics in Clinical